Hayflick limit
Hayflick Limit refers to the phenomenon discovered by Leonard Hayflick in 1961, which states that a normal human cell has a fixed number of times that it can divide before cell division stops, known as cellular senescence. This concept challenged the prevailing belief at the time that cultured cells could proliferate indefinitely. Hayflick's discovery has profound implications for the study of aging, cancer, and cell biology.
Background[edit]
The Hayflick Limit is named after Leonard Hayflick, who, while working at the Wistar Institute in Philadelphia, observed that fibroblast cells derived from human fetal tissue could only divide a certain number of times. He found that these cells could divide approximately 50 times before entering a phase where they no longer proliferate, a state now known as senescence. This was in contrast to the prevailing view, based on work by Alexis Carrel, which suggested that cells could replicate indefinitely if provided with the right conditions.
Mechanism[edit]
The Hayflick Limit is closely associated with the length of telomeres, repetitive nucleotide sequences at the ends of chromosomes. With each cell division, telomeres shorten, acting as a kind of biological clock. Once telomeres reach a critically short length, cells enter senescence and cease to divide. This mechanism is thought to protect against cancer, as the unlimited division of cells with damaged DNA could lead to tumor formation.
Telomerase, an enzyme that adds nucleotide sequences to the ends of telomeres, can extend the lifespan of cells, including stem cells and cancer cells, which often express telomerase and can divide beyond the Hayflick Limit. This has implications for cancer research and regenerative medicine.
Implications[edit]
The Hayflick Limit has significant implications for various fields of biology and medicine. In aging research, it provides a cellular basis for the aging process and suggests potential interventions to extend healthspan. In cancer research, understanding how cancer cells bypass the Hayflick Limit can aid in the development of therapies that target these mechanisms. Additionally, the manipulation of telomerase activity in stem cells holds promise for regenerative medicine and tissue engineering.
Controversy[edit]
The discovery of the Hayflick Limit was initially controversial, as it contradicted the widely accepted belief in the immortality of cultured cells. Over time, however, Hayflick's findings were validated by other researchers, and the concept of the Hayflick Limit is now a fundamental principle in the study of cellular biology.
See Also[edit]
References[edit]
This gerontology related article is a stub. You can help WikiMD by expanding it.
Hayflick limit[edit]
-
DNA orbit animated
-
Hayflick Limit (1)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian